Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
ResMed Inc. has reported an impressive 11% year-over-year revenue increase for the first quarter of fiscal year 2025, reaching $1.2 billion. The company’s operating profit surged by 34%, with significant contributions from their sleep devices, masks portfolio, and Residential Care Software business. As ResMed celebrates 35 years of growth, it continues to focus on transforming sleep and healthcare technology with its 2030 strategy.
For further insights into AU:RMD stock, check out TipRanks’ Stock Analysis page.